MedPath

The study of the effects of general anesthesia using Remimazolam on vital signs such as cardiovascular and blood pressure in surgical patients

Not Applicable
Conditions
All diseases that require surgery under general anesthesia
Registration Number
JPRN-UMIN000044311
Lead Sponsor
Kindai University Faculty of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients under the age of 20 at the time of obtaining the consent form 2) Patients with allergies, hypersensitivity or tolerance to the drugs used 3) Patients who meet the contraindications listed in the package insert of the drug to be used 4) Patients with AST (GOT) or ALT (GPT) of 100 IU / L or more in preoperative general clinical examination 5) Patients with Child-Pugh classification B or C 6) Patients with serum creatinine of 2.0 mg / dL or higher in general preoperative laboratory tests 7) Patients who have been using benzodiazepines for a long time 8) Patients with organic abnormalities in the brain who may not be able to properly measure EEG and BIS values 9) Patients scheduled to undergo epidural anesthesia / spinal anesthesia 10) Patients with cardiac pacemakers and ICDs 11) Lactating patients (except with the positive consent of the patient) 12) Other patients judged to be inappropriate by the principal investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1, ECG (RR interval, Tp-e, QTc time) 2, Blood pressure 3, Heart rate, pulse rate
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath